VIJAY BAJAJ

Allopathic & Osteopathic Physicians|Internal Medicine PALOS HILLS, IL NPI 1508997982

General Payments — all program years on this page

$1,390.95

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 23
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,234.92 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,234.9212

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $487.874
Janssen Pharmaceuticals, Inc $254.442
Gilead Sciences, Inc. $125.001
Vanda Pharmaceuticals Inc. $123.991
Acerta Pharma LLC $95.561
Novo Nordisk AS $92.101
DAVOL INC. $55.962

By program year

Program yearAmountRecords
2018 $57.225
2019 $71.614
2020 $27.202
2024 $1,234.9212

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078012418 Janssen Pharmaceuticals, Inc $124.45 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078012420 Janssen Pharmaceuticals, Inc $129.99 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097010369 Novo Nordisk Inc $92.10 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104379349 AstraZeneca Pharmaceuticals LP $95.56 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115436924 Amgen Inc. $121.86 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115436928 Amgen Inc. $124.99 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115436932 Amgen Inc. $116.03 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115436936 Amgen Inc. $124.99 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127656252 Davol Inc. $39.23 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127656254 Davol Inc. $16.73 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133762062 Gilead Sciences, Inc. $125.00 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133895787 Vanda Pharmaceuticals Inc. $123.99 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.